Antitumor agent-29
Antitumor agent-29 is a hepatocyte-targeting prodrug designed for liver cancer research. It demonstrates potent efficacy in both in vitro cytotoxicity assays and in vivo hepatocellular carcinoma models, while maintaining a favorable toxicity profile.
Product Specifications
CAS Number
2847856-44-2
Smiles
O=C1C=2C3=C (C (=CC2) N4CCN (C (OCCSSCCOC (NC (COCC5=CN (N=N5) [C@@H]6O[C@H] (CO) [C@H] (O) [C@H] (O) [C@H]6O) (COCC7=CN (N=N7) [C@@H]8O[C@H] (CO) [C@H] (O) [C@H] (O) [C@H]8O) COCC9=CN (N=N9) [C@@H]%10O[C@H] (CO) [C@H] (O) [C@H] (O) [C@H]%10O) =O) =O) CC4) C=CC=C3C (=O) N1CC%11=CN (CC (=C) [C@H]%12C[C@@H] (C (C) =C) [C@@] (C=C) (C) CC%12) N=N%11
Molecular Formula
C71H96N16O24S2
Molecular Weight
1621.75
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15271959 1 Vial
Lentiviral mouse Tceal9 shRNA (UAS) - Lentiviral mouse Tceal9 shRNA (UAS, iRFP) (100)
Sign In for Pricing
View Details 